1q gain is a frequent finding in preoperatively treated Wilms tumors, but of limited prognostic value for risk stratification in the SIOP2001/GPOH trial
- 18 July 2014
- journal article
- letter
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 53 (11) , 960-962
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Gain of 1q is a marker of poor prognosis in Wilms' tumorsGenes, Chromosomes and Cancer, 2013
- Gain of 1q is associated with inferior event‐free and overall survival in patients with favorable histology Wilms tumor: A report from the Children's Oncology GroupCancer, 2013
- Stromal and epithelial predominant Wilms tumours have an excellent outcome: The SIOP 93 01 experiencePediatric Blood & Cancer, 2010
- Results of the SIOP 93-01/GPOH Trial and Study for the Treatment of Patients with Unilateral Nonmetastatic Wilms TumorKlinische Padiatrie, 2004
- Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhoodMedical and Pediatric Oncology, 2002